Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04221464Recruiting
Open-label, single-arm trial in peritoneal carcinomatosis (PC), sponsored by Institut du Cancer de Montpellier. Primary endpoint: Proportion of patients who gave their consent to participate in the study at 4 years. Started Nov 2019; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04221464.